Johnson & Johnson’s CVRx CVRX Stock Holding History

Johnson & Johnson’s Portfolio CVRX Stock Details CVRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.1M	Hold	4,024,861	–	–	5.84%	5
2025 Q4	$28.6M	Sell	4,024,861 -78,569	-2%	-$717K	5.15%	5
2025 Q3	$33.1M	Hold	4,103,430	–	–	6.57%	5
2025 Q2	$23.9M	Hold	4,103,430	–	–	7.15%	6
2025 Q1	$50.2M	Hold	4,103,430	–	–	14.68%	2
2024 Q4	$52M	Hold	4,103,430	–	–	13.46%	2
2024 Q3	$36.2M	Hold	4,103,430	–	–	8.46%	5
2024 Q2	$49.2M	Hold	4,103,430	–	–	12.28%	3
2024 Q1	$74.7M	Buy	4,103,430 +607,855	+17%	+$14.4M	1.69%	3
2023 Q4	$110M	Hold	3,495,575	–	–	2.51%	2
2023 Q3	$53M	Hold	3,495,575	–	–	19.53%	2
2023 Q2	$54M	Hold	3,495,575	–	–	16.76%	3
2023 Q1	$32.6M	Hold	3,495,575	–	–	10.6%	4
2022 Q4	$64.1M	Hold	3,495,575	–	–	18.66%	2
2022 Q3	$32.6M	Hold	3,495,575	–	–	9.6%	4
2022 Q2	$21M	Hold	3,495,575	–	–	5.37%	6
2022 Q1	$20.9M	Hold	3,495,575	–	–	3.96%	9
2021 Q4	$42.8M	Hold	3,495,575	–	–	4.87%	7
2021 Q3	$57.8M	Buy	+3,495,575	New	+$67.1M	5.07%	6

Other funds holding CVRX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GSK plc London $599M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Johnson & Johnson's CVRX Position: Q1 2026 in Review

Johnson & Johnson held its CVRx (CVRX) position steady in Q1 2026 at 4,024,861 shares worth $38.1M. The position accounts for 5.84% of the portfolio, ranked #5.

Johnson & Johnson first reported a position in CVRX in Q3 2021 and has held it in 19 quarters since. The position peaked at $110M in Q4 2023. 99 funds tracked by Wall St. Rank hold CVRX as of Q1 2026.

Johnson & Johnson held 4,024,861 shares of CVRx worth $38.1M as of Q1 2026.
Johnson & Johnson left its CVRx share count unchanged in Q1 2026.
CVRx made up 5.84% of Johnson & Johnson's portfolio in Q1 2026, its #5 holding.
Johnson & Johnson first reported a position in CVRx in Q3 2021 and has held it in 19 quarters since.
Johnson & Johnson's CVRx position peaked at $110M in Q4 2023.
99 funds tracked by Wall St. Rank held CVRx as of Q1 2026.

Based on Johnson & Johnson's 13F filing for Q1 2026, filed 13 May 2026.